Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
about
Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluidsGlycosylation-Based Serum Biomarkers for Cancer Diagnostics and PrognosticsTargeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approachSialic acid linkage differentiation of glycopeptides using capillary electrophoresis - electrospray ionization - mass spectrometryCharacterization of the Human Cervical Mucous ProteomeAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.The N-glycome of human plasma.Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissuesIntegration of the transcriptome and glycome for identification of glycan cell signatures.Protein analysis by shotgun/bottom-up proteomicsProstate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples.Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells.A systematic framework to derive N-glycan biosynthesis process and the automated construction of glycosylation networks.Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate HyperplasiaCharacterization of the Glycosylation Site of Human PSA Prompted by Missense Mutation using LC-MS/MS.Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous systemInterlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012Pre-activation-based one-pot synthesis of an alpha-(2,3)-sialylated core-fucosylated complex type bi-antennary N-glycan dodecasaccharide.Toward fully synthetic homogeneous beta-human follicle-stimulating hormone (beta-hFSH) with a biantennary N-linked dodecasaccharide. synthesis of beta-hFSH with chitobiose units at the natural linkage sites.Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.Recent progress and perspectives on prostate cancer biomarkers.Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies.Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective.Seminal plasma glycoproteins in male infertility and prostate diseases: is there a chance for glyco-biomarkers?Aberrant PSA glycosylation--a sweet predictor of prostate cancer.LC-MS/MS in the routine clinical laboratory: has its time come?Expression of LacdiNAc groups on N-glycans among human tumors is complexThe role of glycans in the development and progression of prostate cancer.Can glycoprofiling be helpful in detecting prostate cancer?Large scale biosynthesis of ganglioside analogues by RERF-LC-AI cells cultured in HYPERFlask.Tyramide signal amplification for antibody-overlay lectin microarray: a strategy to improve the sensitivity of targeted glycan profiling.alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification.Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays.LC-MS/MS identification of the O-glycosylation and hydroxylation of amino acid residues of collagen α-1 (II) chain from bovine cartilageGlycoproteomics: identifying the glycosylation of prostate specific antigen at normal and high isoelectric points by LC-MS/MS.
P2860
Q24644593-CA271B14-508F-4AC6-8D9B-A04874A5D61EQ26778227-D8B1A97E-3578-4C48-81CB-4D7770816BB4Q28481264-84E8E6E6-A632-4901-BBF8-ECF9F63D8053Q33807752-F19E696D-BFDD-4347-B4BB-965FDB649D2DQ33816706-1C7ECF98-3BBE-45A5-A439-B003EB82485FQ33995843-480D5A5A-1301-47B7-80BD-AA47A094B499Q34104742-B93ECE15-8A7B-4CAB-8EEE-3FD46E3A7FB4Q34381513-70F7D44C-0AB7-49E3-8E7E-12305B24FA8EQ34541208-868A0FA0-4B64-4C13-BEE2-8031EF1F0BACQ34550700-9091D26B-240D-421C-91EC-4B0356BEB282Q34600986-F4927263-C677-45F7-9388-C1A41F2616BCQ35194458-28363D1A-B378-4BC7-8C70-B866D6C13321Q35927329-C2A9B639-E1EC-4617-9541-C604701C02E2Q36084452-9525DC29-3378-4A5C-8137-618314443CBFQ36737765-53E65BD4-56A8-4713-9138-4EA2350F73D6Q36900678-B838704A-01CB-4017-B545-E6EB75211E8DQ36970387-9384A249-9D54-4440-B947-89FA071279A5Q37154456-C3D67DA6-6186-493B-B233-4C6EEEA1986BQ37214705-B920557B-9B9E-4CDC-9C67-AA91CD25614CQ37322664-B5F0AC82-E213-4BBE-8A2D-A2342D5648B2Q37373965-BC16D689-14EF-4AD2-81AE-0D11EA0A5452Q37672628-4D35DFC9-55D4-4726-8963-E0584719EBFDQ37691113-CF48DED4-4336-4CA3-AE7F-E3D9CFDDA79DQ37736079-4799AF77-BE33-4064-BD70-604E85DF8F33Q37993590-DABB1532-2385-446D-B705-58ECAAA1D9B1Q38034447-5D62A37E-01CB-4CB9-90AA-0813D7E11CAEQ38051694-20ED6A91-1597-4128-B1B9-CEEDB6FED6ADQ38074010-6162698C-340F-433D-8B40-5E75035628A1Q38171274-8EC9A6F7-F902-4DA1-8BD2-127016BE8AF3Q38227185-9085D7D6-8457-43C3-BBFE-1B7E04615FC7Q38811520-5AB9B879-DC94-47D3-AC3C-A8AE29736A07Q38852467-E38CFB3E-FE09-440C-959D-EE296836AFCCQ39329432-36EB3F32-5A79-4AD3-8A56-D879DFC75FDBQ39623545-798BF06D-B52D-4157-916E-62F6D593FCBCQ39763616-44573C8D-3DC4-45C5-B8DB-0AA3247963B2Q39951477-2C51B2EF-5805-4607-B235-1A3C6120EA0FQ40237929-3A9D0B85-F28C-44A3-904C-5071ED4F9A5BQ40408281-412D5FBB-A092-4AEA-91D9-B75FB6FEB1F3Q41557548-F122191E-24E1-43E9-8F8B-F7C3B4DF3B28Q42559393-BDABA8E5-C415-43A9-B62F-8DCCD444E52D
P2860
Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@ast
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@en
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@nl
type
label
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@ast
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@en
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@nl
prefLabel
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@ast
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@en
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@nl
P2093
P356
P1433
P1476
Oligosaccharide profiles of th ...... asma: a glycopeptide approach.
@en
P2093
Chikara Ohyama
Michiko Tajiri
Yoshinao Wada
P356
10.1093/GLYCOB/CWM117
P577
2007-10-23T00:00:00Z